Maternal microchimerism in pediatric inflammatory bowel disease

Chimerism

Volumn 2, Issue 2, 2011, Pages 50-54

  Suskind, David L ^a   Kong, Denice ^b   Stevens, Anne ^a   Wahbeh, Ghassan ^a   Christie, Denise ^a   Baxter Lowe, Lee Ann ^c   Muench, Marcus O ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Crohn's disease; Inflammatory bowel disease; Microchimerism; Pediatrics; Ulcerative colitis

Indexed keywords

DNA;

ADOLESCENT; ADULT; ALLOIMMUNITY; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; ENGRAFTMENT; ENTERITIS; FEMALE; FETOPLACENTAL UNIT; FETUS CIRCULATION; FLUORESCENCE IN SITU HYBRIDIZATION; GRANULOMA; HLA TYPING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; INTESTINE BIOPSY; KINETIC POLYMERASE CHAIN REACTION; MALE; MATERNAL MICROCHIMERISM; MICROCHIMERISM; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; SCHOOL CHILD; ULCERATIVE COLITIS;

EID: 79960765360     PISSN: 19381956     EISSN: 19381964     Source Type: Journal    
DOI: 10.4161/chim.2.2.16556     Document Type: Article

References (28)

1. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007; 448:427-34.
2. Assche EL, Susanne C. Increase in the amount of fetal lymphocytes in maternal blood during pregnancy. J Med Genet 1980; 17:267-72.
3. Lo YM, Lo ES, Watson N, Noakes L, Sargent IL, Thilaganathan B, et al. Two-way cell traffic between mother and fetus: biologic and clinical implications. Blood 1996; 88:4390-5.
4. Ocejo-Vinyals JG, Lozano MJ, Sanchez-Velasco P, Escribano de Diego J, Paz-Miguel JE, Leyva-Cobian F. An unusual concurrence of graft versus host disease caused by engraftment of maternal lymphocytes with DiGeorge anomaly. Arch Dis Child 2000; 83:165-9.
5. Muller SM, Ege M, Pottharst A, Schulz AS, Schwarz K, Friedrich W. Transplacentally acquired maternal T lymphocytes in severe combined immunodeficiency: a study of 121 patients. Blood 2001; 98:1847-51.
6. Washington K, Jagasia M. Pathology of graft-versushost disease in the gastrointestinal tract. Hum Pathol 2009; 40:909-17.
7. Guy-Grand D, Vassalli P. Gut injury in mouse graftversus- host reaction. Study of its occurrence and mechanisms. J Clin Invest 1986; 77:1584-95.
8. Anderson BE, McNiff JM, Matte C, Athanasiadis I, Shlomchik WD, Shlomchik MJ. Recipient CD4 T cells that survive irradiation regulate chronic graftversus- host disease. Blood 2004; 104:1565-73.
9. Garcia de Tena J, Manzano L, Leal JC, San Antonio E, Sualdea V, Alvarez-Mon M. Active Crohn's disease patients show a distinctive expansion of circulating memory cd4+cd45ro+cd28null t cells. j clin immunol 2004; 24:185-96.
10. Hashino S, Mori A, Kobayashi S, Tanaka J, Musashi M, Asaka M, et al. Proliferation of CD4+ lymphocytes in a patient with chronic graft-versus-host disease after allogeneic bone marrow transplantation. Int J Hematol 2000; 71:389-93.
11. Roman LI, Manzano L, De La Hera A, Abreu L, Rossi I, Alvarez-Mon M. Expanded CD4+CD45RO+ phenotype and defective proliferative response in T lymphocytes from patients with Crohn's disease. Gastroenterology 1996; 110:1008-19.
12. Sato T, Kanai T, Watanabe M, Sakuraba A, Okamoto S, Nakai T, et al. Hyperexpression of inducible costimulator and its contribution on lamina propria T cells in inflammatory bowel disease. Gastroenterology 2004; 126:829-39.
13. Wirtz S, Neurath MF. Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease. Int J Colorectal Dis 2000; 15:144-60.
14. Claesson MH, Bregenholt S, Bonhagen K, Thoma S, Moller P, Grusby MJ, et al. Colitis-inducing potency of CD4+ T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype. J Immunol 1999; 162:3702-10.
15. Claesson MH, Rudolphi A, Kofoed S, Poulsen SS, Reimann J. CD4+ T lymphocytes injected into severe combined immunodeficient (SCID) mice lead to an inflammatory and lethal bowel disease. Clin Exp Immunol 1996; 104:491-500.
16. Rudolphi A, Boll G, Poulsen SS, Claesson MH, Reimann J. Gut-homing CD4 T cell receptor alpha beta+ T cells in the pathogenesis of murine inflammatory bowel disease. Eur J Immunol 1994; 24:2803-12.
17. Rudolphi A, Bonhagen K, Reimann J. Polyclonal expansion of adoptively transferred CD4+ alpha beta T cells in the colonic lamina propria of scid mice with colitis. Eur J Immunol 1996; 26:1156-63.
18. Scheerens H, Hessel E, de Waal-Malefyt R, Leach MW, Rennick D. Characterization of chemokines and chemokine receptors in two murine models of inflammatory bowel disease: IL-10-/- mice and Rag-2-/- mice reconstituted with CD4+CD45RBhigh T cells. Eur J Immunol 2001; 31:1465-74.
19. De Winter H, Cheroutre H, Kronenberg M. Mucosal immunity and inflammation. II. The yin and yang of T cells in intestinal inflammation: pathogenic and protective roles in a mouse colitis model. Am J Physiol 1999; 276:G1317-21.
20. Leach MW, Bean AG, Mauze S, Coffman RL, Powrie F. Inflammatory bowel disease in C.B-17 scid mice reconstituted with the CD45RBhigh subset of CD4+ T cells. Am J Pathol 1996; 148:1503-15.
21. Powrie F, Leach MW, Mauze S, Caddle LB, Coffman RL. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol 1993; 5:1461-71.
22. Lambert NC, Erickson TD, Yan Z, Pang JM, Guthrie KA, Furst DE, et al. Quantification of maternal microchimerism by HLA-specific real-time polymerase chain reaction: studies of healthy women and women with scleroderma. Arthritis Rheum 2004; 50:906-14.
23. Chen JC, Chang ML, Lee H, Muench MO. Haploidentical donor T cells fail to facilitate engraftment but lessen the immune response of host T cells in murine fetal transplantation. Br J Haematol 2004; 126:377-84.
24. Mold JE, Michaelsson J, Burt TD, Muench MO, Beckerman KP, Busch MP, et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 2008; 322:1562-5.
25. Adams Waldorf KM, Nelson JL. Autoimmune disease during pregnancy and the microchimerism legacy of pregnancy. Immunol Invest 2008; 37:631-44.
26. Khosrotehrani K, Bianchi DW. Multi-lineage potential of fetal cells in maternal tissue: a legacy in reverse. J Cell Sci 2005; 118:1559-63.
27. Reed W, Kong DZ, Lee TH, Cowan MJ, Busch MP, Baxter-Lowe LA. Non-invasive determination of the paternal HLA haplotype of a fetus using kinetic PCR to detect fetal microchimerism in maternal plasma. Bone Marrow Transplant 2002; 29:527-9.
28. Suskind DL, Rosenthal P, Heyman MB, Kong D, Magrane G, Baxter-Lowe LA, et al. Maternal microchimerism in the livers of patients with biliary atresia. BMC Gastroenterol 2004; 4:14.